STELLARIS PHARMACEUTICALS ApS: Financial statements 2024
CVR: 34708215
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
STELLARIS PHARMACEUTICALS ApS (CVR 34708215) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -336,355 and a net result of DKK -486,941 compared with DKK -803,430 the year before. Equity in the 2024 report amounted to DKK -2,970,934. The company had 1 employee in the financial year.
- Gross Profit
- DKK -336,355
- Profit/Loss
- DKK -486,941
- Equity
- DKK -2,970,934
- Total Assets
- DKK 989,314
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -336 t. | -487 t. | -3 mio. | 1 |
| 2023 | - | -256 t. | -803 t. | -2.5 mio. | 1 |
| 2022 | - | -162 t. | -786 t. | -1.7 mio. | 1 |
| 2021 | - | -102 t. | -539 t. | -895 t. | 1 |
| 2020 | - | -101 t. | -79 t. | -356 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2023. Gross profit came to DKK -255,845, and the net result was DKK -803,430.
About STELLARIS PHARMACEUTICALS ApS
STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.